Page 25 - Terminology-Clinical-Research
P. 25

is responsible for protecting the public health by making   and Drug Administration, Centers for Disease Control
         sure that human and veterinary drugs, vaccines and other   and Prevention, U.S. Department of Veterans Affairs); 3.
         biological products, medical devices, the Nation’s food   Industry (pharmaceutical and device companies); and,
         supply, cosmetics, dietary supplements, and products that   4. All others (including individuals, universities, and
         give off radiation are safe, effective, and secure.    community-based organizations).

         Forest plot (FP): Where there are a number of studies   Fusion proteins: Proteins created through the joining
         that have looked at a treatment, or subgroups of patients   of two or more genes which were originally coded for
         within one study that may respond differently to treatment,   separate proteins.
         a forest plot (FP) is a way to show and compare different
         groups of data.                                        FWA: Federal wide Assurance.

         Form: A collection of items and item groups for capturing
         and displaying clinical trial data.

         Formulation (formulation of a drug): The chemical                              G
         composition of the final medicinal product which includes
         the active ingredient as well as other ingredients (non-
         medicinal ingredients).
                                                                Gas chromatography (GC): A process by which the
         Frequentist methods: Statistical methods, such as      components of a mix are separated from one another
         significance tests and confidence intervals, which can be   by volatilizing the sample into a carrier gas stream and
         interpreted in terms of the frequency of certain outcomes   passing the gas through a column containing a substance
         occurring in hypothetical repeated realizations of the same   that selectively retains (adsorbs) and releases the volatile
         experimental situation.                                constituents.

         Frozen: Status of a database, file, or element that has been   Gender: Subject self-identification re: masculine/feminine.
         presumed to be in its final state pending “lock” and where   Genders eligible for study: The physical gender of people
         further editing is prevented without “unfreezing.” Note:   who may participate in a clinical study (Female, Male, or
         Freezing and unfreezing are usually formalized in audit   Both).
         trails and differ from “locking” and “unlocking” only in the
         degree of approval required.                           Gene therapy medical product: Product aimed at the
                                                                transfer of a prophylactic, diagnostic or therapeutic gene to
         Full analysis set: The set of subjects that is as close as   human and its subsequent expression in vivo.
         possible to the ideal implied by the intention-to treat
         principle. It is derived from the set of all randomized   Gene therapy: A technique for the treatment of genetic
         subjects by minimal and justified elimination of subjects.  disease in which a gene that is absent or defective is
                                                                replaced by a healthy gene.
         Full title of the trial: The title as specified in the study
         protocol and other documents submitted as part of the   Generalizability: The extent to which the findings of a
         Clinical Trial Application.                            clinical trial can be reliably extrapolated from the subjects
                                                                who participated in the trial to a broader patient population
         Functional name of contact point: The point of contact   and a broader range of clinical settings.
         for further information on the trial (e.g. “Clinical Trial
         Information Desk”).                                    Generic drugs: A medicine with the same active
                                                                ingredient, but not necessarily the same inactive
         Functional role (in a study): See Role.
                                                                ingredients, as a brand-name drug. A generic drug may be
         Funder type: Describes the organization that provides   marketed only after the original drug’s patent has expired.
         funding or support for a clinical study. Support may include   Generic name: The drug identifying name to which
         providing facilities, expertise, or financial resources.   all branded (proprietary) names for that indication are
         Organizations listed as Sponsors and Collaborators for a   associated.
         study are considered the funders of the study. There are
         four types of funders: 1. National Institutes of Health;   Global assessment variable: A single variable, usually
         2. Other U.S. Federal agencies (for example, the Food   a scale of ordered categorical ratings, which integrates


                                             TERMINOLOGY CLINICAL RESEARCH                                        25
   20   21   22   23   24   25   26   27   28   29   30